Citigroup Inc. |
August 13, 2024
Medium-Term Senior Notes,
Series G
Pricing Supplement No. 2024-CMTNG1522
Filed Pursuant to Rule 424(b)(2)
Registration Statement No.
333-270327 |
Callable Zero Coupon Notes Due August 15, 2039
| · | The notes mature on the maturity date specified below, subject to our right to call the notes for mandatory redemption prior to maturity
on any redemption date specified below. The notes do not pay any interest. Instead, the amount that you receive upon mandatory
redemption at our option or at maturity, as applicable, will reflect an accretion on the stated principal amount at the accrual yield
specified below. |
| · | The notes are unsecured senior debt obligations of Citigroup Inc. All payments due on the notes are subject to the credit risk
of Citigroup Inc. |
| · | It is important for you to consider the information contained in this pricing supplement together with the information contained
in the accompanying prospectus supplement and prospectus. The description of the notes below supplements, and to the extent inconsistent
with replaces, the description of the general terms of the notes set forth in the accompanying prospectus supplement and prospectus. |
KEY TERMS |
Issuer: |
Citigroup Inc. Upon at least 15 business days’
notice, any wholly owned subsidiary of Citigroup Inc. may, without the consent of any holder of the notes, assume Citigroup Inc.’s
obligations under the notes, and in such event Citigroup Inc. shall be released from its obligations under the notes, subject to
certain conditions, including the condition that Citigroup Inc. fully and unconditionally guarantee all payments under the notes.
See “Additional Terms of the Notes” in this pricing supplement. |
Stated principal amount: |
$1,000 per note |
Pricing date: |
August 13, 2024 |
Original issue date: |
August 15, 2024 |
Maturity date: |
Unless earlier redeemed, August 15, 2039. If the maturity date is not a business day, then the payment required to be made on the maturity date will be made on the next succeeding business day with the same force and effect as if it had been made on the maturity date. No interest or yield will accrue as a result of delayed payment. |
Payment at maturity: |
Unless earlier redeemed, the accreted value as of the maturity date, for a payment at maturity equal to $2,200.00 per $1,000 stated principal amount note. |
Interest: |
The notes do not pay any interest |
Accrual yield: |
8.00% per annum (non-compounding) based on the stated principal amount (using a 360-day year composed of twelve 30-day months) |
Redemption: |
Beginning on August 15, 2025, we have the right to call the notes for
mandatory redemption, in whole but not in part, on any redemption date for an amount equal to the accreted value as of the applicable
redemption date. See “Redemption Schedule” below for the accreted value applicable to each redemption date. If we decide to
redeem the notes, we will give you notice at least five business days before the redemption date specified in the notice.
So long as the notes are represented by global securities and are
held on behalf of The Depository Trust Company (“DTC”), redemption notices and other notices will be given by delivery to
DTC. If the notes are no longer represented by global securities and are not held on behalf of DTC, redemption notices and other notices
will be published in a leading daily newspaper in New York City, which is expected to be The Wall Street Journal. |
Redemption dates: |
The 15th day of each August, beginning in August 2025. If any redemption date is not a business day, the payment required to be made on that redemption date will be made on the next succeeding business day with the same force and effect as if it had been made on that redemption date. No interest or yield will accrue as a result of delayed payment. |
Accreted value: |
As of any date, the accreted value for each $1,000 stated principal amount note is the stated principal amount plus an additional amount that accrues on the stated principal amount from and including the original issue date to but excluding that date at the accrual yield. |
CUSIP / ISIN: |
17290ALH1 / US17290ALH13 |
Listing: |
The notes will not be listed on any securities exchange. |
Underwriter: |
Citigroup Global Markets Inc. (“CGMI”), an affiliate of the issuer, acting as principal. See “General Information—Supplemental information regarding plan of distribution; conflicts of interest” in this pricing supplement. |
Underwriting fee and issue price: |
Issue price(1) |
Underwriting fee(2) |
Proceeds to issuer |
Per note: |
$1,000.00 |
$30.00 |
$970.00 |
Total: |
$6,504,000.00 |
$114,865.00 |
$6,389,135.00 |
|
|
|
|
|
(Key Terms continued
on next page)
(1) The issue price paid by eligible institutional
investors and investors purchasing the notes in fee-based advisory accounts will vary based on then-current market conditions and the
negotiated price determined at the time of each sale, provided however that the issue price for such investors will not be less than
$970.00 per note and will not be more than $1,000 per note. The issue price for such investors reflects a forgone selling concession
or underwriting fee with respect to such sales as described in footnote (2) below. See “General Information—Fees and selling
concessions” in this pricing supplement.
(2) CGMI will receive an underwriting
fee of up to $30.00 per note, and from such underwriting fee will allow selected dealers a selling concession of up to $30.00 per note
depending on market conditions that are relevant to the value of the notes at the time an order to purchase the notes is submitted to
CGMI. Dealers who purchase the notes for sales to eligible institutional investors and/or to investors purchasing the notes in fee-based
advisory accounts may forgo some or all selling concessions, and CGMI may forgo some or all of the underwriting fee for sales it makes
to eligible institutional investors and/or to investors purchasing the notes in fee-based advisory accounts. The per note underwriting
fee in the table above represents the maximum underwriting fee payable per note. The total underwriting fee and proceeds to issuer in
the table above give effect to the actual total underwriting fee. You should refer to “Risk Factors” and “General Information—Fees
and selling concessions” in this pricing supplement for more information. In addition to the underwriting fee, CGMI and its affiliates
may profit from hedging activity related to this offering, even if the value of the notes declines. See “Use of Proceeds and Hedging”
in the accompanying prospectus.
Investing in the notes involves risks. See “Risk Factors”
beginning on page PS-2.
Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of the notes or determined that this pricing supplement and the accompanying prospectus supplement
and prospectus are truthful or complete. Any representation to the contrary is a criminal offense.
You should read this pricing supplement together
with the accompanying prospectus supplement and prospectus, each of which can be accessed via the following hyperlink:
Prospectus Supplement and Prospectus each dated March 7, 2023
The notes are not bank deposits and are not insured
or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of, or guaranteed
by, a bank.
KEY TERMS (continued) |
Redemption schedule: |
The accreted value applicable to each redemption date is indicated
below: |
|
Redemption Date |
Accreted Value
(per $1,000 Stated Principal Amount Note) |
|
|
August 15, 2025 |
$1,080.00 |
|
|
August 15, 2026 |
$1,160.00 |
|
|
August 15, 2027 |
$1,240.00 |
|
|
August 15, 2028 |
$1,320.00 |
|
|
August 15, 2029 |
$1,400.00 |
|
|
August 15, 2030 |
$1,480.00 |
|
|
August 15, 2031 |
$1,560.00 |
|
|
August 15, 2032 |
$1,640.00 |
|
|
August 15, 2033 |
$1,720.00 |
|
|
August 15, 2034 |
$1,800.00 |
|
|
August 15, 2035 |
$1,880.00 |
|
|
August 15, 2036 |
$1,960.00 |
|
|
August 15, 2037 |
$2,040.00 |
|
|
August 15, 2038 |
$2,120.00 |
|
Business day: |
Any day that is not a Saturday or Sunday and that, in New York City, is not a day on which banking institutions are authorized or obligated by law or executive order to close. |
Risk
Factors
The following
is a non-exhaustive list of certain key risk factors for investors in the notes. You should read the risk factors below together with
the risk factors included in the accompanying prospectus supplement and in the documents incorporated by reference in the accompanying
prospectus, including Citigroup Inc.’s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q,
which describe risks relating to our business more generally. We also urge you to consult your investment, legal, tax, accounting and
other advisors in connection with your investment in the notes.
| § | The
notes do not pay interest. The notes are not appropriate for investors who require regular payments of interest. |
| § | The
notes may be redeemed at our option prior to the maturity date. We may redeem the notes, in whole but not in part, on any redemption
date, upon not less than five business days’ notice. In the event that we redeem the notes, you will receive the accreted value
as of the relevant redemption date. If we elect to redeem the notes prior to maturity, we will do so at a time that is advantageous for
us but when it may not be in your interest for us to do so. For example, we may do so at a time when market interest rates have fallen,
such that you are unable to reinvest your funds in an investment with a yield as great as the accrual yield on the notes. |
| § | The
notes are subject to the credit risk of Citigroup Inc., and any actual or anticipated changes to its credit ratings or credit spreads
may adversely affect the value of the notes. You are subject to the credit risk of Citigroup Inc. If Citigroup Inc. defaults on its
obligations under the notes, your investment would be at risk and you could lose some or all of your investment. As a result, the value
of the notes will be affected by changes in the market’s view of Citigroup Inc.’s creditworthiness. Any decline, or anticipated
decline, in Citigroup Inc.’s credit ratings or any increase, or anticipated increase, in the credit spreads charged by the market
for taking Citigroup Inc. credit risk is likely to adversely affect the value of the notes. |
| § | The
notes will not be listed on any securities exchange and you may not be able to sell them prior to maturity. The notes will not be
listed on any securities exchange. Therefore, there may be little or no secondary market for the notes. CGMI currently intends to make
a secondary market in relation to the notes and to provide an indicative bid price for the notes on a daily basis. Any indicative bid
price for the notes provided by CGMI will be determined in CGMI’s sole discretion, taking into account prevailing market conditions
and other relevant factors, and will not be a representation by CGMI that the notes can be sold at that price or at all. CGMI may suspend
or terminate making a market and providing indicative bid prices without notice, at any time and for any reason. If CGMI suspends or
terminates making a market, there may be no secondary market at all for the notes because it is likely that CGMI will be the only broker-dealer
that is willing to buy your notes prior to maturity. Accordingly, an investor must be prepared to hold the notes until maturity. |
| § | Immediately
following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage account statements
prepared by CGMI or its affiliates, will reflect a temporary upward adjustment. The amount of this temporary upward adjustment will
steadily decline to zero over the temporary adjustment period. See “General Information—Temporary adjustment period”
in this pricing supplement. |
| § | The
notes are riskier than notes with a shorter term. The notes are relatively long-dated, subject to our call right. Because the notes
are relatively long-dated, many of the risks of the notes are heightened as compared to notes with a shorter term, because you will be
subject to those risks for a longer period of time. In addition, the value of a longer-dated note is typically less than the value of
an otherwise comparable note with a shorter term. |
| § | Secondary
market sales of the notes may result in a loss. You will be entitled to receive the then-applicable accreted value of your notes,
subject to the credit risk of Citigroup Inc., only if you hold the notes to maturity or earlier redemption at our option. If you are
able to sell your notes in the secondary market prior to such time, you are likely to receive less than the then-applicable accreted
value of the notes. |
| § | The
inclusion of underwriting fees and projected profit from hedging in the issue price is likely to adversely affect secondary market prices.
Assuming no changes in market conditions or other relevant factors, the price, if any, at which CGMI may be willing to purchase the
notes in secondary market transactions will likely be lower than the then-applicable accreted value since the issue price of the notes
will include, and secondary market prices are likely to exclude, any underwriting fees paid with respect to the notes, as well as the
cost of hedging our obligations under the notes. The cost of hedging includes the projected profit that our affiliates may realize in
consideration for assuming the risks inherent in managing the hedging transactions. The secondary market prices for the notes are also
likely to be reduced by the costs of unwinding the related hedging transactions. Our affiliates may realize a profit from the expected
hedging activity even if the value of the notes declines. In addition, any secondary market prices for the notes may differ from values
determined by pricing models used by CGMI, as a result of dealer discounts, mark-ups or other transaction costs. |
| § | The
price at which you may be able to sell your notes prior to maturity will depend on a number of factors and may be substantially less
than the then-applicable accreted value. A number of factors will influence the value of the notes in any secondary market that may
develop and the price at which CGMI may be willing to purchase the notes in any such secondary market, including: interest rates in the
market and the volatility of such rates, the time remaining to maturity of the notes, hedging activities by our affiliates, any fees
and projected hedging fees and profits, expectations about whether we are likely to redeem the notes and any actual or anticipated changes
in the credit ratings, financial condition and results of Citigroup Inc. The value of the notes will vary and is likely to be less than
the then-applicable accreted value at any time prior to maturity or redemption, and sale of the notes prior to maturity or redemption
may result in a loss. |
| § | The
U.S. federal tax consequences of an assumption of the notes are unclear. The notes may be assumed by a successor issuer, as discussed
in “Additional Terms of the Notes.” The law regarding whether or not such an assumption would be considered a taxable modification
of the notes is not entirely clear and, if the Internal Revenue Service (the “IRS”) were to treat the assumption as a taxable
modification, a U.S. Holder would generally be required to recognize gain (if any) on the notes and the timing and character of income
recognized with respect to the notes after the assumption could be affected significantly. You should read carefully the discussion under
“United States Federal Income Tax Considerations” in this pricing supplement. You should also consult your tax adviser regarding
the U.S. federal tax consequences of an assumption of the notes. |
Additional
Terms of the Notes
Successor
Issuer
The
notes are intended to qualify as eligible debt securities for purposes of the Federal Reserve's total loss-absorbing capacity (“TLAC”)
rule. As a result, in the event of a Citigroup Inc. bankruptcy, Citigroup Inc.'s losses and any losses incurred by its subsidiaries would
be imposed first on Citigroup Inc.’s shareholders and then on its unsecured creditors, including the holders of the notes. Further,
in a bankruptcy proceeding of Citigroup Inc. any value realized by holders of the notes may not be sufficient to repay the amounts owed
on the notes. For more information about the consequences of “TLAC” on the notes, you should refer to the “Citigroup
Inc.” section beginning on page 12 of the accompanying prospectus.
Upon
at least 15 business days’ notice, any wholly owned subsidiary (the “successor issuer”) of Citigroup Inc. may, without
the consent of any holder of the notes, assume all of Citigroup Inc.’s obligations under the notes, and in such event Citigroup
Inc. shall be released from its obligations under the notes (in each case, except as described below), subject to the following conditions:
| (a) | Citigroup Inc. shall enter into a supplemental indenture under which Citigroup Inc. fully and
unconditionally guarantees all payments on the notes when due, agrees to comply with the covenants described in the section “Description
of Debt Securities—Covenants—Limitations on Liens” and “—Limitations on Mergers and Sales of Assets”
in the accompanying prospectus as applied to itself and retains certain reporting obligations under the indenture; |
| (b) | the successor issuer shall be organized under the laws of the United States of America, any
State thereof or the District of Columbia; and |
| (c) | immediately after giving effect to such assumption of obligations, no default or event of default
shall have occurred and be continuing. |
Upon
any such assumption, the successor issuer shall succeed to and be substituted for, and may exercise every right and power of, Citigroup
Inc. under the notes with the same effect as if such successor issuer had been named as the original issuer of the notes, and Citigroup
Inc. shall be relieved from all obligations and covenants under the notes, except that Citigroup Inc. shall have the obligations described
in clause (a) above. For the avoidance of doubt, the successor issuer shall not be responsible for Citigroup Inc.’s compliance
with the covenants described in clause (a) above.
If
a successor issuer assumes the obligations of Citigroup Inc. under the notes as described above, events of bankruptcy or insolvency or
resolution proceedings relating to Citigroup Inc. will not constitute an event of default with respect to the notes, nor will any breach
of a covenant by Citigroup Inc. (other than payment default). Therefore, if a successor issuer assumes the obligations of Citigroup Inc.
under the notes as described above, events of bankruptcy or insolvency or resolution proceedings relating to Citigroup Inc. (in the absence
of any such event occurring with respect to the successor issuer) will not give holders the right to declare the notes to be due and
payable, and a breach of a covenant by Citigroup Inc. (including the covenants described in the section “Description of Debt Securities—Covenants—Limitations
on Liens” and “—Limitations on Mergers and Sales of Assets” in the accompanying prospectus), other than payment
default, will not give holders the right to declare the notes to be due and payable. Furthermore, if a successor issuer assumes the obligations
of Citigroup Inc. under the notes as described above, it will not be an event of default under the notes if the guarantee of the notes
by Citigroup Inc. ceases to be in full force and effect or if Citigroup Inc. repudiates the guarantee.
There
are no restrictions on which subsidiary of Citigroup Inc. may be a successor issuer other than as specifically set forth above. The successor
issuer may be less creditworthy than Citigroup Inc. and/or may have no or nominal assets. If Citigroup Inc. is resolved in bankruptcy,
insolvency or other resolution proceedings and the notes are not contemporaneously declared due and payable, and if the successor issuer
is subsequently resolved in later bankruptcy, insolvency or other resolution proceedings, the value you receive on the notes may be significantly
less than what you would have received had the notes been declared due and payable immediately upon certain events of bankruptcy or insolvency
or resolution proceedings relating to Citigroup Inc. or the breach of a covenant by Citigroup Inc.
The
notes are “specified securities” for purposes of the indenture. The terms set forth above do not apply to all securities
issued under the indenture, but only to the notes offered by this pricing supplement (and similar terms may apply to other securities
issued by Citigroup Inc. that are identified as “specified securities” in the applicable pricing supplement).
You
should read carefully the discussion of U.S. federal tax consequences of any such assumption under “United States Federal Tax Considerations”
in this pricing supplement.
Events
of Default and Acceleration
In
case an event of default (as described in the accompanying prospectus) with respect to the notes shall have occurred and be continuing,
the amount declared due and payable upon any acceleration of the notes will be determined by the calculation agent and will equal, for
each note, the accreted value determined as described herein as of the date of acceleration. Such amount as so determined will constitute
the final payment on the notes, and no additional amounts will accrue with respect to the notes following the date of acceleration.
In
case of default under the notes, in respect of any payment due under the notes, no interest will accrue on such overdue payment either
before or after the maturity date.
General Information |
Temporary adjustment period: |
For a period of approximately six months following issuance of the notes, the price, if any, at which CGMI would be willing to buy the notes from investors, and the value that will be indicated for the notes on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one or more financial information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined. This temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the term of the notes. The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the six-month temporary adjustment period. However, CGMI is not obligated to buy the notes from investors at any time. See “Risk Factors—The notes will not be listed on any securities exchange and you may not be able to sell them prior to maturity.” |
U.S. federal income tax considerations: |
The notes will be treated as debt instruments that are issued with original
issue discount (and without any qualified stated interest) for U.S. federal income tax purposes. As a result, U.S. Holders (as defined
in the accompanying prospectus supplement) will be required to include original issue discount in their taxable income over the term of
the notes on a constant-yield basis, as described in the section of the accompanying prospectus supplement called “United States
Federal Tax Considerations—Tax Consequences to U.S. Holders—Original Issue Discount.” The amount of original issue discount
included in each year on a constant yield basis will be lower than the amount determined by reference to the yield implied by the redemption
schedule described above in “Key Terms,” unless the notes remain outstanding to maturity.
Under their terms, the notes may be assumed by a successor issuer, in
which case we will guarantee the successor issuer’s payment obligations under the notes. See “Additional Terms of the Notes.”
We intend to treat such an assumption as not giving rise to a taxable modification of the notes. While our counsel, Davis Polk & Wardwell
LLP, believes this treatment of such an assumption is reasonable under current law and based on the expected circumstances of the assumption,
it has not rendered an opinion regarding such treatment in light of the lack of clear authority addressing the consequences of such an
assumption. Provided that an assumption of the notes is not a taxable modification, the U.S. federal income tax treatment of the notes
would not be affected by the assumption. However, if the IRS were to treat an assumption of the notes as a taxable modification, the timing
and character of income recognized with respect to the notes after the assumption could be affected significantly, depending on circumstances
at the time of the assumption. Moreover, a U.S. Holder (as defined in the accompanying prospectus supplement) would generally be required
to recognize gain (if any) with respect to the notes at the time of the assumption in the same manner as described in the accompanying
prospectus supplement in respect of a sale or other taxable disposition of the notes. You should consult your tax adviser regarding the
consequences of an assumption of the notes.
Both U.S. and non-U.S. persons considering
an investment in the notes should read the discussion under “United States Federal Tax Considerations,” and in particular
the sections entitled “United States Federal Tax Considerations—Tax Consequences to U.S. Holders,” “—Tax
Consequences to Non-U.S. Holders” and “—FATCA” in the accompanying prospectus supplement for more information
regarding the U.S. federal income tax consequences of an investment in the notes. |
Trustee: |
The Bank of New York Mellon (as trustee under an indenture dated November 13, 2013) will serve as trustee for the notes. |
Use of proceeds and hedging: |
The net proceeds received from the sale of the notes will be used for
general corporate purposes and, in part, in connection with hedging our obligations under the notes through one or more of our affiliates.
Hedging activities related to the notes by one or more of our affiliates
involves trading in one or more instruments, such as options, swaps and/or futures, and/or taking positions in any other available securities
or instruments that we may wish to use in connection with such hedging and may include adjustments to such positions during the term
of the notes. It is possible that our affiliates may profit from this hedging activity, even if the value of the notes declines. Profit
or loss from this hedging activity could affect the price at which Citigroup Inc.’s affiliate, CGMI, may be willing to purchase
your notes in the secondary market. For further information on our use of proceeds and hedging, see “Use of Proceeds and Hedging”
in the accompanying prospectus. |
ERISA and IRA purchase considerations: |
Please refer to “Benefit Plan Investor Considerations” in the accompanying prospectus supplement for important information for investors that are ERISA or other benefit plans or whose underlying assets include assets of such plans. |
Fees and selling concessions: |
The issue price is $1,000 per note; provided that the issue price for
an eligible institutional investor or an investor purchasing the notes in a fee-based advisory account will vary based on then-current
market conditions and the negotiated price determined at the time of each sale. The issue price for such investors will not be less than
$970.00 per note and will not be more than $1,000 per note. The issue price for such investors reflects a forgone selling concession with
respect to such sales as described in the next paragraph.
CGMI, an affiliate of Citigroup Inc., is the underwriter of the
sale of the notes and is acting as principal. CGMI may resell the notes to other securities dealers at the issue price of $1,000 per
note less a selling concession not in excess of the underwriting fee. CGMI will receive an underwriting fee of up to $30.00 per note,
and from such underwriting fee will allow selected dealers a selling concession of up to $30.00 per note depending on market conditions
that are relevant to the value of the notes at the time an order to purchase the notes is submitted to CGMI. Dealers who purchase the
notes for sales to eligible institutional investors and/or to investors purchasing the notes in fee-based advisory accounts may forgo
some or all selling concessions, and CGMI may forgo some or all of the underwriting fee for sales to it makes to eligible institutional
investors and/or to investors purchasing the notes in fee-based advisory accounts. |
Supplemental information regarding plan of distribution; conflicts of interest: |
The terms and conditions set forth in the Amended and Restated Global
Selling Agency Agreement dated April 7, 2017 among Citigroup Inc. and the agents named therein, including CGMI, govern the sale and purchase
of the notes.
The notes will not be listed on any securities exchange.
In order to hedge its obligations under the notes, Citigroup Inc. has
entered into one or more swaps or other derivatives transactions with one or more of its affiliates. You should refer to the section “General
Information—Use of proceeds and hedging” in this pricing supplement and the section “Use of Proceeds and Hedging”
in the accompanying prospectus.
CGMI is an affiliate of Citigroup Inc. Accordingly, the offering of
the notes will conform with the requirements addressing conflicts of interest when distributing the securities of an affiliate set forth
in Rule 5121 of the Conduct Rules of the Financial Industry Regulatory Authority, Inc. Client accounts over which Citigroup Inc., its
subsidiaries or affiliates of its subsidiaries have investment discretion are not permitted to purchase the notes, either directly or
indirectly, without the prior written consent of the client.
See “Plan of Distribution; Conflicts of Interest” in
the accompanying prospectus supplement for more information. |
Paying agent: |
Citibank, N.A. will serve as paying agent and registrar and will also hold the global security representing the notes as custodian for The Depository Trust Company (“DTC”). |
Contact: |
Clients may contact their local brokerage representative. Third party distributors may contact Citi Structured Investment Sales at (212) 723-7005. |
We encourage
you to also read the accompanying prospectus supplement and prospectus, which can be accessed via the hyperlink on the cover page of
this pricing supplement.
Certain
Selling Restrictions
Prohibition
of Sales to EEA Retail Investors
The notes may not be offered, sold or otherwise made
available to any retail investor in the European Economic Area. For the purposes of this provision:
| (a) | the expression “retail investor” means a person who is one (or more) of the following: |
| (i) | a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, “MiFID
II”); or |
| (ii) | a customer within the meaning of Directive 2002/92/EC, where that customer would not qualify as a professional
client as defined in point (10) of Article 4(1) of MiFID II; or |
| (iii) | not a qualified investor as defined in Directive 2003/71/EC; and |
| (b) | the expression “offer” includes the communication in any form and by any means of sufficient
information on the terms of the offer and the notes offered so as to enable an investor to decide to purchase or subscribe the notes. |
Prohibition
of Sales to United Kingdom Retail Investors
The notes
may not be offered, sold or otherwise made available to any retail investor in the United Kingdom. For the purposes of this provision:
| (a) | the expression “retail investor” means a person who is one (or more) of the following: |
| (i) | a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part
of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 (the “EUWA”) and the regulations made
under the EUWA; or |
| (ii) | a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (as
amended) (the “FSMA”) and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer
would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of
United Kingdom domestic law by virtue of the EUWA and the regulations made under the EUWA; or |
| (iii) | not a qualified investor as defined in Regulation (3)(e) of the Prospectus Regulation; and |
| (b) | the expression “offer” includes the communication in any form and by any means of sufficient
information on the terms of the offer and the notes offered so as to enable an investor to decide to purchase or subscribe the notes. |
Notice
to Canadian Investors
The notes
may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined
in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients,
as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the
notes must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable
securities laws.
Securities
legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this pricing
supplement or an accompanying product supplement, prospectus supplement or prospectus (including any amendment thereto) contains a misrepresentation,
provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities
legislation of the purchaser’s province or territory. The purchaser should refer to any applicable provisions of the securities
legislation of the purchaser’s province or territory for particulars of these rights or consult with a legal advisor.
Pursuant
to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (“NI 33-105”), the underwriters are not required to
comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.
Validity
of the Notes
In the opinion
of Davis Polk & Wardwell LLP, as special products counsel to Citigroup Inc., when the notes offered by this pricing supplement have
been executed and issued by Citigroup Inc. and authenticated by the trustee pursuant to the indenture, and delivered against payment
therefor, such notes will be valid and binding obligations of Citigroup Inc., enforceable in accordance with their terms, subject to
applicable bankruptcy, insolvency and similar laws affecting creditors' rights generally, concepts of reasonableness and equitable principles
of general applicability (including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that
such counsel expresses no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law
on the conclusions expressed above. This opinion is given as of the date of this pricing supplement and is limited to the laws of the
State of New York, except that such counsel expresses no opinion as to the application of state securities or Blue Sky laws to the notes.
In giving
this opinion, Davis Polk & Wardwell LLP has assumed the legal conclusions expressed in the opinion set forth below of Karen Wang,
Senior Vice President – Corporate Securities Issuance Legal of Citigroup Inc. In addition, this opinion is subject to the assumptions
set forth in the letter of Davis Polk & Wardwell LLP dated February 14, 2024, which has been filed as an exhibit to a Current Report
on Form 8-K filed by Citigroup Inc. on February 14, 2024, that the indenture has been duly authorized, executed and delivered by, and
is a valid, binding and enforceable agreement of the trustee and that none of the terms of the notes nor the issuance and delivery of
the notes, nor the compliance by Citigroup Inc. with the terms of the notes, will result in a violation of any provision of any instrument
or agreement then binding upon Citigroup Inc. or any restriction imposed by any court or governmental body having jurisdiction over Citigroup
Inc.
In the opinion
of Karen Wang, Senior Vice President – Corporate Securities Issuance Legal of Citigroup Inc., (i) the terms of the notes offered
by this pricing supplement have been duly established under the indenture and the Board of Directors (or a duly authorized committee
thereof) of Citigroup Inc. has duly authorized the issuance and sale of such notes and such authorization has not been modified or rescinded;
(ii) Citigroup Inc. is validly existing and in good standing under the laws of the State of Delaware; (iii) the indenture has been duly
authorized, executed and delivered by Citigroup Inc.; and (iv) the execution and delivery of such indenture and of the notes offered
by this pricing supplement by Citigroup Inc., and the performance by Citigroup Inc. of its obligations thereunder, are within its corporate
powers and do not contravene its certificate of incorporation or bylaws or other constitutive documents. This opinion is given as of
the date of this pricing supplement and is limited to the General Corporation Law of the State of Delaware.
Karen Wang,
or other internal attorneys with whom she has consulted, has examined and is familiar with originals, or copies certified or otherwise
identified to her satisfaction, of such corporate records of Citigroup Inc., certificates or documents as she has deemed appropriate
as a basis for the opinions expressed above. In such examination, she or such persons has assumed the legal capacity of all natural persons,
the genuineness of all signatures (other than those of officers of Citigroup Inc.), the authenticity of all documents submitted to her
or such persons as originals, the conformity to original documents of all documents submitted to her or such persons as certified or
photostatic copies and the authenticity of the originals of such copies.
Additional
Information
We reserve
the right to withdraw, cancel or modify any offering of the notes and to reject orders in whole or in part prior to their issuance.
© 2024
Citigroup Global Markets Inc. All rights reserved. Citi and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or
its affiliates and are used and registered throughout the world.
424B2
EX-FILING FEES
0000831001
333-270327
0000831001
1
2024-08-14
2024-08-14
0000831001
2024-08-14
2024-08-14
iso4217:USD
xbrli:pure
xbrli:shares
Ex-Filing Fees
CALCULATION OF FILING FEE TABLES
S-3
Citigroup Inc.
Table 1: Newly Registered and Carry Forward Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line Item Type |
|
Security Type |
|
Security Class Title |
|
Notes |
|
Fee Calculation Rule |
|
Amount Registered |
|
Proposed Maximum Offering Price Per Unit |
|
Maximum Aggregate Offering Price |
|
Fee Rate |
|
Amount of Registration Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Newly Registered Securities |
Fees to be Paid |
|
Debt |
|
Medium-Term Senior Notes, Series G |
|
(1) |
|
457(r) |
|
6,504 |
|
$ |
1,000 |
|
$ |
6,504,000 |
|
0.0001476 |
|
$ |
959.99 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Offering Amounts: |
|
$ |
6,504,000 |
|
|
|
$ |
959.99 |
Total Fees Previously Paid: |
|
|
|
|
|
|
|
0.00 |
Total Fee Offsets: |
|
|
|
|
|
|
|
0.00 |
Net Fee Due: |
|
|
|
|
|
|
$ |
959.99 |
__________________________________________
Offering Note(s)
(1) | |
The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act. |
Narrative Disclosure
The maximum aggregate offering price of the securities to which the prospectus relates is $6,504,000. The
prospectus is a final prospectus for the related offering.
v3.24.2.u1
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
ffd_FeeExhibitTp |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:feeExhibitTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
ffd_RegnFileNb |
Namespace Prefix: |
ffd_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
ffd_SubmissionLineItems |
Namespace Prefix: |
ffd_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
ffd_SubmissnTp |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
X |
- DefinitionThe amount of securities being registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_AmtSctiesRegd |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:nonNegativeDecimal2ItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTotal amount of registration fee (amount due after offsets).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_FeeAmt |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:nonNegative1TMonetary2ItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_FeeRate |
Namespace Prefix: |
ffd_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe maximum aggregate offering price for the offering that is being registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_MaxAggtOfferingPric |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:nonNegative100TMonetary2ItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe maximum offering price per share/unit being registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_MaxOfferingPricPerScty |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:nonNegativeDecimal4lItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_OfferingNote |
Namespace Prefix: |
ffd_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe title of the class of securities being registered (for each class being registered).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_OfferingSctyTitl |
Namespace Prefix: |
ffd_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionType of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_OfferingSctyTp |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:securityTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
ffd_OfferingTable |
Namespace Prefix: |
ffd_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
ffd_PrevslyPdFlg |
Namespace Prefix: |
ffd_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 457 -Subsection r
+ Details
Name: |
ffd_Rule457rFlg |
Namespace Prefix: |
ffd_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
ffd_OfferingAxis=1 |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.24.2.u1
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_FeesSummaryLineItems |
Namespace Prefix: |
ffd_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_FnlPrspctsFlg |
Namespace Prefix: |
ffd_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_NetFeeAmt |
Namespace Prefix: |
ffd_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_NrrtvMaxAggtOfferingPric |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:nonNegative100TMonetary2ItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_TtlFeeAmt |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:nonNegative1TMonetary2ItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_TtlOfferingAmt |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:nonNegative1TMonetary2ItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_TtlOffsetAmt |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:nonNegative1TMonetary2ItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_TtlPrevslyPdAmt |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:nonNegative1TMonetary2ItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Citigroup (NYSE:C)
過去 株価チャート
から 7 2024 まで 8 2024
Citigroup (NYSE:C)
過去 株価チャート
から 8 2023 まで 8 2024